Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence study of generic fluticasone propionate versus Flixotide in mild to moderate persistent asthma
2005-006077-27Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate in asthma (2 arms), sponsored by Merck & Co. Primary endpoint: Morning peak expiratory flow rate. Started May 2006; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-006077-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006077-27.